• CASO CLÍNICO ROSIGLIATAZONE EVALUATED FOR CARDIOVSCULAR OUTCOMES IN ORAL AGENT COMBINATION THERAPY FOR TYPE 2 DIABETES (RECORD): A MULTICENTRE, RANDOMISED, OPEN –LABEL…

ROSIGLIATAZONE EVALUATED FOR CARDIOVSCULAR OUTCOMES IN ORAL AGENT COMBINATION THERAPY FOR TYPE 2 DIABETES (RECORD): A MULTICENTRE, RANDOMISED, OPEN –LABEL TRIAL. PHILIP…

ENARM 2011 CASO CLÍNICO ROSIGLIATAZONE EVALUATED FOR CARDIOVSCULAR OUTCOMES IN ORAL AGENT COMBINATION THERAPY FOR TYPE 2 DIABETES (RECORD): A MULTICENTRE, RANDOMISED, OPEN…

ENARM 2011 CASO CLÍNICO ROSIGLIATAZONE EVALUATED FOR CARDIOVSCULAR OUTCOMES IN ORAL AGENT COMBINATION THERAPY FOR TYPE 2 DIABETES (RECORD): A MULTICENTRE, RANDOMISED, OPEN…

1. Immune System What do you already know about the immune system? 2. Expressed on the surface of B cells and in a secreted form with very high avidity. Eliminates pathogens…

1. COMMON VARIABLE IMMUNODEFICIENCY (CVID) Abdullatiff Sami Al-Rashed 2. Objectives • What is Immunoglobulin (Ig)? • CVID • Hyper IgM Syndrome 3. What is Immunoglobulin…

the biomechanics of the foot (during gait for example) with the inter-relationships between rear foot and fore foot, the common pathologies treated with orthotics and how…